Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy
Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cell...
Guardado en:
Autores principales: | , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a72 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:91d687fcae1f40e2bbb08d73a1ee3a72 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:91d687fcae1f40e2bbb08d73a1ee3a722021-12-02T10:49:30ZGraphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy10.1038/s41598-021-81218-32045-2322https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a722021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-81218-3https://doaj.org/toc/2045-2322Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency.Ran LiYimei WangJie DuXiangyu WangAilin DuanRuifang GaoJunyu LiuBing LiNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-10 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Ran Li Yimei Wang Jie Du Xiangyu Wang Ailin Duan Ruifang Gao Junyu Liu Bing Li Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
description |
Abstract In the present work, we constructed nanoscale graphene oxide (NGO) as a drug nanocarrier to improve the process of tumor-targeted drug releases, promote cellular uptake and accumulation of chemotherapy drugs in tumor tissues, and reduce the toxic effects of chemotherapy drugs on normal cells. Hence, great stability was obtained in the biological solution. Moreover, we designed an effective nanoparticle system for the doxorubicin (DOX) delivery targeting the oral squamous cell carcinoma (OSCC) by mediating the HN-1 (TSPLNIHNGQKL) through hydrogen and π–π bonds. DOX@NGO-PEG-HN-1 showed significantly higher cellular uptakes and cytotoxicity in OSCC cells (CAL-27 and SCC-25), compared to free DOX. Moreover, HN-1 showed considerable tumor-targeting and competition inhibition phenomenon. As we expected, the nanocarrier showed pH-responsive drug release. In total, our study represented a good technique to construct OSCC-targeted delivery of nanoparticles and improve the anticancer medicines’ efficiency. |
format |
article |
author |
Ran Li Yimei Wang Jie Du Xiangyu Wang Ailin Duan Ruifang Gao Junyu Liu Bing Li |
author_facet |
Ran Li Yimei Wang Jie Du Xiangyu Wang Ailin Duan Ruifang Gao Junyu Liu Bing Li |
author_sort |
Ran Li |
title |
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
title_short |
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
title_full |
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
title_fullStr |
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
title_full_unstemmed |
Graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
title_sort |
graphene oxide loaded with tumor-targeted peptide and anti-cancer drugs for cancer target therapy |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/91d687fcae1f40e2bbb08d73a1ee3a72 |
work_keys_str_mv |
AT ranli grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT yimeiwang grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT jiedu grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT xiangyuwang grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT ailinduan grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT ruifanggao grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT junyuliu grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy AT bingli grapheneoxideloadedwithtumortargetedpeptideandanticancerdrugsforcancertargettherapy |
_version_ |
1718396604823633920 |